Jill Feldman: Behind Every Biomarker is a Person
Jill Feldman, Co-Founder of EGFR Resister, shared a post on X about recent paper by Maxime Borgeaud et al., published in CA: A Cancer Journal for Clinicians.
“Behind every biomarker is a person.
It was an honor to co-author this comprehensive review on optimizing treatment for EGFRm NSCLC.
It isn’t easy for a patient/advocate to contribute meaningfully to long, technical articles, but that’s exactly why it’s so important that we do.
This work reflects collaboration and respect. A huge thanks to the authors for valuing the patient perspective.”
Title: Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Authors: Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Pei Li Saw, Kaushal Parikh, Giuseppe Luigi Banna, Claudio De Vito, Jill Feldman, Xiuning Le, Alfredo Addeo
Read The Full Article at CA: A Cancer Journal for Clinicians.
More posts featuring Jill Feldman on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023